In clinic, cardiologist Sudarshan Rajagopal, MD, PhD, has no means to cure most patients with pulmonary hypertension, not the narrowing of blood vessels in their lungs, not damage done to their hearts.

The physician-scientist can prescribe medicines that extend the lives of many patients, but the precious gains can come with unwelcome costs.

“All these drugs help open blood vessels in the lungs and help treat heart failure. But they can have horrible side effects,” Rajagopal says, including nausea, diarrhea, weight loss and other side effects.

But help may come from complex pharmacology studies that Rajagopal first encountered at Duke in the laboratory of Nobel Prize winner Robert Lefkowitz, MD.

Sudarshan Rajagopal, MD, assistant professor of medicine (Cardiology), will present his research at the Department's Research Seminar Series on Friday, May 27, 2016 in Duke Hospital Room 2002. Dr. Rajagopal will discuss biasing receptor signaling to understand human disease.

Four faculty from the Department of Medicine will be awarded The Butler Pioneer Award for Outstanding Young Physician-Scientists, a generous beques

Subscribe to RajagopalSudarshan